1208307-50-9Relevant academic research and scientific papers
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines
Lin, Hong,Yamashita, Dennis S.,Xie, Ren,Zeng, Jin,Wang, Wenyong,Leber, Jack,Safonov, Igor G.,Verma, Sharad,Li, Mei,LaFrance, Louis,Venslavsky, Joseph,Takata, Dennis,Luengo, Juan I.,Kahana, Jason A.,Zhang, Shuyun,Robell, Kimberly A.,Levy, Dana,Kumar, Rakesh,Choudhry, Anthony E.,Schaber, Michael,Lai, Zhihong,Brown, Barry S.,Donovan, Brian T.,Minthorn, Elisabeth A.,Brown, Kristin K.,Heerding, Dirk A.
scheme or table, p. 684 - 688 (2010/06/14)
The synthesis and evaluation of tetrasubstituted aminopyridines, bearing novel azaindazole hinge binders, as potent AKT inhibitors are described. Compound 14c was identified as a potent AKT inhibitor that demonstrated reduced CYP450 inhibition and an improved developability profile compared to those of previously described trisubstituted pyridines. It also displayed dose-dependent inhibition of both phosphorylation of GSK3β and tumor growth in a BT474 tumor xenograft model in mice.
